Dosimetry in brain tumor phantom at 15 MV 3D conformal radiation therapy by Larissa Thompson et al.
Thompson et al. Radiation Oncology 2013, 8:168
http://www.ro-journal.com/content/8/1/168
RESEARCH Open Access
Dosimetry in brain tumor phantom at 15 MV
3D conformal radiation therapy
Larissa Thompson1*, Humberto Galvão Dias2 and Tarcísio Passos Ribeiro Campos3
Abstract
Glioblastoma multiforme (GBM) is the most common, aggressive, highly malignant and infiltrative of all brain tumors
with low rate of control. The main goal of this work was to evaluate the spatial dose distribution into a GBM simulator
inside a head phantom exposed to a 15MV 3D conformal radiation therapy in order to validate internal doses. A head
and neck phantom developed by the Ionizing Radiation Research Group (NRI) was used on the experiments. Such
phantom holds the following synthetic structures: brain and spinal cord, skull, cervical and thoracic vertebrae, jaw,
hyoid bone, laryngeal cartilages, head and neck muscles and skin. Computer tomography (CT) of the simulator was
taken, capturing a set of contrasted references. Therapy Radiation planning (TPS) was performed based on those CT
images, satisfying a 200 cGy prescribed dose split in three irradiation fields. The TPS assumed 97% of prescribed dose
cover the prescribed treatment volume (PTV). Radiochromic films in a solid water phantom provided dose response as
a function of optical density. Spatial dosimetric distribution was generated by radiochromic film samples at coronal,
sagittal-anterior and sagittal-posterior positions, inserted into tumor simulator and brain. The spatial dose profiles held
70 to 120% of the prescribed dose. In spite of the stratified profile, as opposed to the smooth dose profile from TPS,
the tumor internal doses were within a 5% deviation from 214.4 cGy evaluated by TPS. 83.2% of the points with a
gamma value of less than 1 (3%/3mm) for TPS and experimental values, respectively. At the tumor, measured at
coronal section, a few dark spots in the film caused the appearance of outlier points in 13-15% of dose deviation
percentage. And, as final conclusion, such dosimeter choice and the physical anthropomorphic and anthropometric
phantom provided an efficient method for validating radiotherapy protocols.
Introduction
Glioblastoma multiforme (GBM) is the most aggressive
brain tumor. Two to three new cases per 10,000 inhab-
itants a year are reported in most European countries
[1]. GBM corresponds to about 75% of all high-grade
gliomas. Prognosis is poor, with average survival of just
12 to 16 months [2,3]. According to the American Can-
cer Society (ACS), about 22,340 malignant brain or spinal
cord tumors will be diagnosed per year in the United
States of America (USA), resulting in 13,110 deaths [4].
After a GBM diagnosis, the prognosis is poor [5-9] and
median overall survival is less than one year [8], due to
the uncontrollable infiltrative capability of such tumor [2].
Despite its uniformly lethal course, the survival of patients
with GBM varies considerably [10]. In general, extensive
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portions of the brain are involved. GBM, depending on
location, may be surgically removed. Radiotherapy pre-
scribes daily absorbed doses of 1.8Gy to 2.0Gy, 5 days a
week, reaching about 60Gy [2]. Normal tissue capability
to withstand radiation without deleterious effects depends
on prescribed dose, irradiated tissue volume, tissue sen-
sitivity, previous irradiation history, and personal radio
sensitivity [11]. GBM local management is still a chal-
lenge, either on its initial stages or on recidivations [12].
In spite of GBM’s high degree of malignancy, recent stud-
ies show that survival rate has doubled in the last 30 years,
due to advances in radiotherapy, surgery and chemother-
apy. In the 1990’s, less than one in ten GBMpatients would
survive for more than six months. According to Beckford
[13], half of such patients would survive for at least a year
after diagnosis. That study stated that 17% of all primary
brain tumors were GBM and less than 4% of those patients
remained alive after 5 years.
© 2013 Thompson et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Radiotherapy’s goal is to deliver a lethal accumulated
dose on the tumor, while sparing adjacent healthy tissues
from radiation’s detrimental effects [14]. In spite of being
an effective treatment for GBM, radiotherapy’s deleteri-
ous side effects depend on the tumor’s oxygenation [15].
Brain tumors have a lower oxygen tension than normal
surrounding cortex, making them more radio-resistant.
Usually, survival rate is correlated to total radiation dose.
Above 70Gy, however, toxic effects on surrounding brain
tissue overcome benefits from improved tumor control.
Preserving the patient’s life quality is important in this
context [15].
Precise evaluation of the doses at the tumor and sur-
rounding regions is essential to maximize the treatment’s
benefits. Thus, spatial dose distribution on either homo-
geneous or heterogeneous, solid phantoms is essential in
order to validate radiotherapy planning, assuring qual-
ity and reproducibility of the exposures [16]. Dosimetry
comprises determination of both quantitative dose and
its spatial distribution, absorbed by several parts of the
human body from internal or external radiation sources.
Precise dosimetric evaluation is highly desirable, but chal-
lenging due to three factors: (1) possibility of several
different exposure scenarios, even for a single spatial and
temporal relationship between source and human body;
(2) different exposure mechanisms due to distinct radia-
tion physical properties, such as those of x-rays, gamma
rays, electrons, positrons, neutrons, alpha particles, heavy
ions or protons; (3) variations of density, anatomical shape
and chemical composition present in the human body,
which also changes with respiration and cardiac rhythm.
Such factors make choosing representative parameters for
the interaction between radiation and the human body
a very complex problem [14]. The phantom used in this
work is a static tool, however, the influence of movement
and reproducibility were not prioritized. Due to GBM’s
low survival rate treatment should be reevaluated, in par-
ticular the verification of the dose absorbed at the tumor
provided by the current radiotherapy protocols.
Dosimetric film Gafchromic EBT2 was designed by
International Specialty Product (ISP) for radiotherapy
applications [17,18]. Gafchromic EBT2’s energy depen-
dency is very weak in a wide range of radiation beam
quality in radiotherapy [18]. EBT2 film’s chemical com-
position is equivalent to soft tissue (ZWatereff Film = 6.84,
compared to ZWatereff Soft Tissue = 7.3). It provides good spatial
resolution (< 0.1mm) and may be submerged in water. It
is, therefore, a good dosimetric tool for measuring per-
cent depth dose (PDD) [19]. Gafchromic EBT2 has high
sensitivity up to 80Gy and, thus, may be used to mea-
sure absorbed dose in conformal radiotherapy, besides
other modalities [20]. In fact, dose may be evaluated from
1 cGy to 10Gy by readout on visible frequencies close to
red and up to 40Gy in the green light component [20].
Dosimetric films are able to register information with
high spatial resolution while suffering little to none dis-
tortion in high-gradient regions, which are problematic
for ionization chambers. Gafchromic EBT2 may be used
as an alternative dosimeter for measuring dose depth per-
centage in megavoltage radiotherapy, for a wide range of
energetic beams [19]. Despite the use of radiochromic
films becoming routine in radiotherapy, spatial dose dis-
tributions in internal organs or even in tumor simulators
have not been investigated, probably due to the reduced
number of appropriated phantoms with internal organs
available for conducting those experiments [21-23].
Two distinct spatial dose distributions, e.g. from TPS
and experimental, may be compared based on quantita-
tive parameters. The gamma index method, as presented
by Low et al. [24] and Depuydt et al. [25], provided a dose-
difference criterion, DM, and the distance to agreement
(DTA) criterion, dM, in order to evaluate and analyze an
n-dimensional set of spatial distributed data comparing
measured and calculated sets. The method incorporates
dose and distance criteria, providing a numerical quality
index that represents a level of agreement or disagreement
in a tested region.
Previous studies show dosimetric measurement results
by using radiochromic dosimeters in homogeneous and
heterogeneous phantoms. Butson et al. [26] mentions
investigation of radiochromic film for use in dosimetry in
water phantoms as opposed to solid phantoms, and that
the penetration rates of water into radiochromic film are
measured in order to assess their effects on optical den-
sity. The effects of film orientation during irradiation in
water were also tested. Butson et al. [26] included that
the radiochromic film seems to be an adequate detec-
tor for dosimetry in a water phantom where high spatial
resolution is needed [26]. Albertini et al. [27] performed
measurements in an anthropomorphic phantom in order
to investigate clinical relevant intensity modulated pro-
ton therapy (IMPT) treatment plans. Albertini et al. [27]
had two goals: to assess plan accuracy in the presence
of high heterogeneity and to measure plan robustness in
the presence of treatment uncertainties. A phantom with
five different tissue substitute materials, simulating differ-
ent tissue types, and Gafchromic films were used. Their
results showed excellent agreement between the calcu-
lated and the measured dose distribution: > 99% and
98% of points with a gamma value < 1 (3%/3 mm) for
the 3D-IMPT and the DET plan, respectively. Nakano
et al. [28] developed a study quantifying surface doses on
several rectangular phantom setups and on curved sur-
face phantoms for a 6 MV photon field using the Attix
parallel-plate chamber and Gafchromic EBT2 film. Their
results indicate the important role of the presence of bolus
if the clinical target volume (CTV) is quite close to the
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surface, and demonstrates the suitability of Gafchromic
EBT2 film for surface dose measurements in megavolt-
age photon beams. Horsfield [29] investigated EBT2 film
irradiation with three different head and neck inten-
sity modulated radiation therapy treatment plans using
the CIRSTManthropomorphic phantom using the gamma
analysis criterion of 3mm5%, resulting in 90% agree-
ment between the planned treatment and the measured
values.
The main goal of this work is the evaluation of the
spatial internal dose distribution in a anthropomorphic
and anthropometric head and neck phantom with a GBM
simulator inserted into the brain, at a central position,
submitted to a three-field conformal radiotherapy 3D.
Materials andmethods
Simulators, dosimeters and radiological imaging
A physical head and neck phantom developed by the
NRI Research Group [21-23], including a GBM simula-
tor, was used in our experiments. The GBM simulator
was made from tissue equivalent material and incorpo-
rated into the anthropomorphic and anthropometric head
and neck phantom’s brain. The equivalent tissues compo-
sition of head phantom was prepared based on a mixture
of selected chemical materials, in stoichiometric propor-
tions, that achieve the elemental human composition pro-
vided by ICRU-44. A set of chemical compounds and their
weight proportions has been chosen in order to repro-
duce the elemental composition and mass density of the
brain, bone, cartilage, muscle and skin tissues. All were
prepared by synthetic materials. The required composi-
tions were reached using water or jelly mixtures as the
base material, based on carboxymethylcellulose and poly-
methylmetacrylate. The brain and the tumor tissues were
prepared with agar-agar as base material [23]. That sim-
ulator weights 55 g and its volume is 20.05 cm3. It was
inserted into the central region of the brain, affecting both
hemispheres.
The chosen dosimeter was the radiochromic film
Gafchromic EBT2 (lot number F020609). Such film has
been used for radiation therapy dosimetry, being sensitive
to daily exposure levels prescribed in current protocols
[19]. Three groups of ten segments of Gafchromic EBT2,
1.0 × 1.5 cm each, were used in the calibration process.
Three segments, two of 5×3 cm and one of 10×3 cm, were
used for evaluating spatial dose distribution in the tumor.
Those film samples, handled with surgical gloves, were cut
and stored in an black envelope in order to protect them
from any external damages such as scratches, moisture or
light exposure.
The film samples were inserted into the physical phan-
tom, positioned vertically in relation to the base of the
skull, in a cross pattern, at the center of the GBM simula-
tor. The following spatial orientations were adopted: two
sagittal segments, anterior and posterior, and one coronal
segment, from right to left. Film segments thus covered
not only the tumor simulator, but also part of the adjacent
equivalent tissue corresponding to brain. CT images of
the physical phantom with the inserted film samples were
taken at a Siemens SOMATON Emotion 6 system with
2mm slices, 54.80 mGy dose, 108.8 mAs, 130 kV , mul-
tislice volume. Exact locations of the GBM simulator and
the film segments inside the physical phantom were iden-
tified by radio-opaque markers. After the CT scans, the
film segments were replaced by new ones, with the same
dimensions, from the same lot and placed at the same
orientation as the previous ones.
Radiotherapy planning
Radiotherapy planning was based on the CT phantom
images, digitized in DICOM mode. The image set was
stored in a database. The prescribed dose was defined
by the Radiation Therapy Oncology Group (RTOG) vol-
ume prescribed technique in which 97% of the dose covers
the prescribed treatment volume (PTV). The irradiation
target volume was delimited and a dose of 200 cGy was
prescribed, so that all the target volume was covered.
Radiotherapy planning on the physical phantom was per-
formed by CAT3D for Win32 software version 7.08e.
Planning was based on the brain tumor protocol sug-
gested by the Radiotherapy Service of Luxemburgo Hos-
pital, Belo Horizonte, Brazil. The film segments inserted
into the physical head and neck phantom, designated as
coronal (C), sagittal-anterior (SA) and sagittal-posterior
(SP) received a single fraction of 200.0 cGy as target dose.
The region of interest received the irradiation of three
fields: antero-posterior 6.0 × 7.0 cm, lateral-right 6.0 ×
7.5 cm, and lateral-left 6.0 × 7.5 cm. The technique was
3D isocentric conformal radiotherapy, with gantry angle
of 0° antero-posterior, 270° lateral-right and 90° lateral-
left, with wedge W30 filters at the lateral fields. Monitor
units were 93.4, 90.3 and 88.8 cGy at the antero-posterior,
lateral-right and lateral-left fields, respectively. For cal-
ibration purposes, temperature and pressure inside the
irradiation room were measured, and a calibration coeffi-
cient KPT = 1.1297 determined. The particle accelerator
was also calibrated so that 1 cGy would correspond to 1
Monitor Unit (MU).
Dosimeter calibration was performed using a water
phantom, an acrylic box filled with water, developed
by the NRI Research Group. Such phantom has 4mm
walls and external dimensions of 304 × 308 × 308mm.
At the center of the box there was an adjustable sup-
port. Alongside its height there were ten square holes,
to support ten horizontal brackets of 5 × 5 × 100mm.
Such brackets held the film pieces during the calibra-
tion process. The distance between holes was 2.0 cm
center-to-center, lowest hole 6.5 cm from the bottom
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and highest hole 4.5 cm from the top. The brackets
have cuts to hold the film pieces. The film piece on
the topmost bracket was covered by 3.0 cm of water,
ensuring electronic equilibrium. Exposure was measured
by ionization chamber and dose converted at the film
samples’ positions, generating the percent depth dose
profile. The calibration of the 15 MV beam was prepared
based on the Technical Report 398 [30]. The uncertainty
from dose calibration is a constant value independent of
the dose.
Percent depth dose evaluation and simulator irradiation
Percent dose depth (PDD) profile was generated using the
water phantom. At this point, 30 film pieces were set aside
in three groups of ten segments each. Each film group
was positioned, affixed in depth on the ten horizontal
brackets inside the water phantom. A rectangular radia-
tion field of 10×10 cmwas standardized. The isocenter of
the film piece set was at 100 cm of the accelerator’s isocen-
ter (source-surface distance - SSD). The planned dose
was divided in three distinct ranges: 224.0 to 109.0 cGy
(group I), 111.5 to 54.3 cGy (group II), and 55.3 to 26.9 cGy
(group III). Irradiation protocol was repeated for each
group.
Exposure of the dosimeter set on the water phantom
and on the physical phantom itself were both performed at
the Radiotherapy Service of Luxemburgo Hospital / Mário
Penna Institute. The linear accelerator used for calibra-
tion and irradiation procedures was Linac Saturne 2 CGR,
15MV , cGy/MU = 1.000, for 6 and 15MV , with nominal
dose rate of 200 MU/min.
The phantom was held by a styrofoam support. Posi-
tioning followed the references from CT phantom images
and the external, physical markings on the phantom’s
outer surface, reproducing the orthogonal laser orienta-
tion captured at the moment of the CT scan (7.2mm to
the left, 6.8mm backwards and 0.0mm towards the top of
the head). Exposure was performed in the convolution -
pencil beam mode, 8 × 8mm. The films were placed in
a cross-shaped pattern, perpendicular to each other. The
three radiation beams were also applied at 90° each other.
However, they were applied with an angular tilt deviation
from the film plane to the beam isocenter, in order to have
the beam crossing the film while avoiding being parallel
to the interface between film and brain. The isocenter of
the film was defined based on small sphere markers made
of lead.
Digitalization and dosimeter readout
Digitalization of the exposed film samples was performed
with a regular table scanner, HP Scanjet G4050, operating
in transmission mode. It occurred 24h after exposure,
ensuring that the film was fully self-developed. The scan-
ner was warmed up for half an hour, in order to stabilize
the temperature of its light bulb. Five sweeps of unexposed
Gafchromic EBT2 film, and one of overexposed radiog-
raphy film, were performed in order to prevent possible
noise and artifacts, as suggested by [31]. Overexposed
film, unexposed film, and the irradiated film samples were
then digitalized as slides, using the scanner’s Transpar-
ent Materials Adapter (TMA), with the following settings:
300 pixels per inch (ppi), RGB (Red, Green, Blue) mode,
48 bits, 16 bits per color. The resulting files were in TIFF
and JPEG format. The 30 calibration film samples were
scanned together at the center of the scanner. After that,
the three irradiation film samples were also scanned.
The digitalization process resulted in six groups of
images: one unexposed film sample, one overexposed film
sample, three film samples irradiated at the physical head
and neck phantom (C, SA and SP), and three groups of
ten film samples irradiated at the water phantom, for a
total of 35 film samples. Digital images were analyzed on
the ImageDig software package [32]. Color intensity in
RGB mode was obtained, assuming a range from 0 to 255
on each component. Red and Green components from
the film samples were thus measured. Mean value of nine
measured points and standard deviation were calculated
for the Red (mRed and σRed) and Green (mGreen e σGreen)
components. The RGB pixel values were used rather than
the physical quantity I.
Optical density, standard deviation and dose response
Film exposure to radiation promoted darkening on red
and green components. Optical density (OD) values and
respective standard deviation (σOD) were calculated from
measurements of color components’ intensities. A film





where I0 is the RGB intensity on unexposed film, and I
is the intensity on irradiated film. m(RGBunexposed) and
m(RGBirradiated) were used as I0 and I, respectively. OD’s
standard deviation is given by [31,33]:
σOD(D) = 1ln 10
√
σ(RGBunexposed)2 + σ(RGBoverexposed)2
(m(RGBunexposed) − m(RGBoverexposed))2 +
σ(RGBirradiated)2 + σ(RGBoverexposed)2
(m(RGBirradiated) − m(RGBoverexposed))2 .
(2)
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m(RGBunexposed) and σ(RGBunexposed) are average and
standard deviation of unexposed film, m(RGBoverexposed)
and σ(RGBoverexposed) are average and standard deviation
of overexposed radiographic film, and m(RGBirradiated)
and σ(RGBirradiated) are average and standard deviation
of the irradiated film’s color components, either red or
green. Equation (2) was used in order to calculate stan-
dard deviations for each color component, red or green,
individually.
Dose response was obtained assuming a linear relation
between dose and optical density, within the exposure
range on the experiment. The standard deviation for dose
was as prescribed by technical report 398, and the stan-
dard deviation for optical density was calculated as in Eq 2.
A linear regression between optical density and calibra-
tion dose was calculated. OD behaves linearly in relation
to dose, even though I0/I behaves exponentially. The rela-
tionship between optical density and dose was evaluated
for each of the three 10-sample calibration groups, and for
the unexposed film. Calibration curves were generated by
OriginLab Data Analysis and Graphing Software 6.1 for
each component, red and green, independently [34].
Absorbed dose on the GBM simulator
After digitalization and readout of the radiochromic film
samples, as described above, absorbed dose on the GBM
simulator was evaluated. Optical densities registered on
C, SA and SP film samples were evaluated at pixels of
the images. From dose versus optical density responses,
for each dose interval, optical densities were converted
to doses and plotted. Dose spatial distribution was thus
generated for C, SA and SP film samples.
Gamma-index and dose deviation percentage evaluation
Three sets of data and associated matrices Mc(i, j),
Mm(i, j) and Mt(i, j) were selected, two of them related
to spatial dose distribution and one referring to a tar-
get organ position. Those matrices are representative of
the three bidimensional segments taken from: a section
of the therapy planning system (TPS), a section of a
Gafchromic film detector, and a part of the photographic
representation of the tumor, respectively. The two dose
distribution matrices provide the calculated dose Dc(i, j)
from TPS and the measured dose Dm(i, j) estimated by
the Gafchromic films at red component. The target organ
position matrix Mt(i, j) was obtained from digitalization
and processing of a photography of the tumor section
where the radiochromic film was placed into. Each ele-
ment of the Mt(i, j) matrix holds one bit, zero or one,
representing whether the corresponding position belongs
or not to the target organ. The reference size length and
width of the bidimensional segments of the calculated
and measured dose distributions were also provided. The
quality index γ (rm) corresponding to the measurement
point rm, in the evaluated tumor area, with modular dis-
tance between rc and rm positions, and dose differences
Dc(rc) andDm(rm) obtained fromMc andMm matrix data
were evaluated. The gamma-index method and its criteria
of acceptance were applied as described in the literature
[24,25], but only to the tumor target area. The passing
criteria adopted on this experiment were DM = 3% and
dM = 3 mm, as suggested by Low et al. [24]. The com-
parisons were repeated for all measurement points rm, and
a bidimensional representation of the gamma-index was
obtained. Dose deviation percentage between TPS and
measured data was also evaluated at the tumor, limited to
the coronal section.
Dose volume histogram
Despite being a 2D representation of a 3D dose distri-
bution, a dose volume histogram (DVH) was obtained
from data at the tumor section. Its volume corresponds
the portion of the film representing the tumor, a slice
where radiation is absorbed. The histogram accounts for
the portion of the volume that receives a specific dose or
more. DVHsmay be constructed as differential DVH’s and
cumulative DVH’s. They were created by first determin-
ing the size of the histogram dose bins, arbitrarily defined




Figure 1 shows the water phantom, the physical head and
neck phantom, followed by the image of a CT section of
the phantom. The cross pattern positioning and spacing
of the film samples inside the head and neck phantom is
also depicted.
CAT3D radiotherapy planning on the physical phantom
Figure 2 shows details of the radiotherapy planning for
the physical head and neck phantom. Projections of the
three fields, anterior-posterior, lateral-right and lateral-
left, are shown superimposed to the 3D-reconstructed
images of the phantom’s skull on Figure 2A. Figure 2B
shows the isodose curves planned on the region of inter-
est, with the target (tumor simulator) delimited. Figure 2C
shows the three irradiation fields, taken on the coordi-
nate axes. The planning details are also presented: 40% of
the dose (80 cGy) on the anterior-posterior field, 30% of
the dose (60 cGy) on the lateral-right field and 30% of the
dose (60 cGy) on the lateral-left, covering the tumor sim-
ulator with 100% of the dose. Isodose curves are shown
for 100% of the dose (200 cGy), 95% of the dose (190 cGy),
90% of the dose (180 cGy) and 50% of the dose (100 cGy).
Tumor simulator limits and the two bilateral wedge filters
are also shown.
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Figure 1 Simulators. (A) water phantom for calibration, (B) physical
head and neck phantom, (C) CT section of the physical phantom with
GBM simulator and film samples inserted.
Figure 2 Radiotherapy planning details. (A) region of interest
(cranial) and the three irradiation fields (antero-posterior, lateral-right,
lateral-left), (B) region of interest and target delimitation (tumor
simulator) and (C) the three fields (40% of the dose anterior, 30% right
and 30% left), and respective isodose levels and two wedge filters.
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Figure 3 shows phantom positioning and the irradia-
tion fields. CT image and the physical markings on the
phantom were used as references.
Dose versus response relation
Curves for optical density as function of dose were
obtained from optical density values and their stan-
dard deviations for each component, red and green, in
RGB. After line fitting, the calibration curve representing
dose as function of optical density on exposed film was
expressed as:
D = A · OD + B, (3)
where A is line inclination and B is the intersection with
the ordinate axis.
Figures 4 and 5 show film calibration curves for red
and green components, respectively. A linear regression
between dose and OD was calculated. After line fitting,
parameters for the dose as function of optical density were
found, for red and green components.
Absorbed dose on GBM simulator
The spatial distribution of absorbed dose in the GBM sim-
ulator inside the physical head and neck phantom was
obtained by applying optical density values into dose-
response function. Dose distributions from red and green
components on films C, SA and SP generated 3D graphs
showing dose as function of position. Figures 6 and 7 show
those spatial distributions, red and green components,
respectively. Figure 8 shows the percent dose deviations
measured on red component compared to green compo-
nent, on C, SA and SP films. The small deviation values
from calculated dose and red and green components show
that both may be used for dosimetric evaluations in the
range from 20 to 230 cGy.
Figure 3 Phantom positioning in relation to the accelerator
gantry. Planning and beam positioning indicated, based on the CT
images.
Figure 4 Calibration curves, red component. Calibration curves for
the three film groups and line fitting, red component.
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Figure 5 Calibration curves, green component. Calibration curves
for the three film groups and line fitting, green component.
Gamma-index and dose deviation percentage results
Figure 9C shows the results of gamma-index analysis
applied to the tumor area. Values lesser than unit corre-
spond to points from the image that have passed on the
gamma-index criteria. All those rm points, measured by
radiochromic film enclosed by the tumor, provide limit
points rc, in the calculation matrix produced by TPS,
whose distance r and dose difference D from rm are
enclosed by the 2D ellipsoid defined by DM and dM
parameters.
Figure 9D shows dose deviation percentage fromDc and
Dm at the tumor area. Almost all points are in the two
deviation intervals 1-3% and 3-5%. A few areas are in the
9-11% interval, and there are some stray points where film
darkness provided the appearance of dose deviations in
the higher interval, 13-15%.
Dose volume histogram
Figure 10 presents cumulative and differential dose-
volume histograms (DVH’s). The DVH’s summarize dose
distributions at the section of the film corresponding to
the tumor, relating volume percentage to maximum dose
percentage. The volume implicit in the DVH analysis cor-
responds to the arbitrary tumor target section in which
the radiochromic film was placed. In the differential DVH,
column height indicates the volume of the structure which
received a dose given by the volume bin. In the cumulative
DVH, column height of the volume bin 85% represents the
percentage of the structure volume which received a dose
greater than or equal to 214.2 cGy. No volume greater than
1 mm3 received 90%, which corresponds to doses greater
than or equal to 239 cGy.
Discussion
The main original characteristics of this study, compared
to previous works [26,27,28,29], are the use of an anthro-
pomorphic and anthropometric phantom which takes
into account the heterogeneity of the human body and the
adoption of a protocol, 3D conformal radiotherapy, actu-
ally used in a reference hospital for treatment of patients.
In contrast with more controlled experimental setups,
our experiment aims to reproduce realistic conditions,
even with many possible sources of error, and improv-
ing the evaluation of actual internal doses at the brain.
Those insights may be used for improving the quality of
radiotherapy treatment.
The phantom was built with the head tilted in rela-
tion to the neck (hyper extended), so that it could be also
utilized for head and neck dosimetry. Despite that, irra-
diation of the synthetic tumor at the center of the brain
was performed equivalently to the human case. A sup-
port for the head was used so that its position relative to
the beam orientation and entry points was as prescribed
by the three field 15MV conformational radiation therapy
protocol used for brain tumors. The size of such support
required some lowering of the bed, in order to achieve cor-
rect beam. On this experiment, the influence of phantom
movement was not considered. The experiment may be
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Figure 6 Spatial dose distribution, red component. Spatial dose distribution measured on red component, on C, SA and SP films,
surface-contour mode.
repeated, but there are no means of ascertaining the exact
same dosimeter positioning due to phantom-film physi-
cal manipulation, therefore each experiment is unique and
cannot yield exactly the same results.
The low attenuations of the 15MV beam at a 20 cm
depth required use of three calibration levels, correspond-
ing to three distinct exposure ranges, measured by the
three sets of ten film segments each. It was possible then
to obtain a dose response versus optical density for the
26 to 224 cGy interval. In the present work, however,
EBT2 film was selected and doses were measured on two
components, red and green. Calibration with Gafchromic
EBT2 film samples inside the water phantom followed
similar protocols available in the literature [31,33]. Cali-
bration curves have shown that optical densities increased
linearly with dose for both components at the studied dose
interval.
Dose distribution on coronal film, red component,
showed an absorbed dose of 210 to 220 cGy (105 to 110%)
on most of the film area, which is not statistically differ-
ent from the prescribed dose value (PD) of 200 cGy ± 5%.
Hot regions with 220 to 230 cGy (110 to 115% of the PD)
were observed, however, and even a few hotspots with
230 to 240 cGy (115 to 120% of the PD) were present. The
same pattern of spatial dose distribution was observed on
the green component. Such hotspots were not identified
on the radiotherapy planning. Red and green components
provide dosimetric evaluations in the range from 20 to 230
cGy. Despite the fact that those responses are from dif-
ferent wavelengths, both come from the same dosimeter
and are not independent. Variation between dose mea-
surements on red and green components went from−4 to
6%, showing that both results were equivalent.
Dose distribution on sagittal-anterior e sagittal-posterior
film samples, red component, showed that absorbed dose
was between 210 and 220 cGy (105 to 110% of the PD).
Those values are within the prescribed range. There were,
however, regions with doses from 220 to 230 cGy (110
to 115% of the PD). The same spatial dose distribution
pattern was observed on the green component, with devi-
ations from 0 to 2%. Those small deviation values from
calculated dose and red and green components show that
both may be used for dosimetric evaluations in the range
from 20 to 230 cGy, and one may be used to cross-validate
the other. Sagittal-anterior film showed a cold region
within 140 to 150 cGy (70 to 75% of the PD). Such area
Figure 7 Spatial dose distribution, green component. Spatial dose distribution measured on green component, on C, SA and SP films,
surface-contour mode.
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Figure 8 Percent deviations, red and green components. Percent deviations of measured doses from red and green components, on C, SA and
SP films, respectively.
Figure 9 Gamma-index and histogram results. (A) Cross-section of part of the synthetic brain and the tumor area; (B) projection of the tumor
section in which the coronal film was placed; (C) gamma-index values at tumor area; and (D) dose deviation percentage, from measured and TPS
doses at tumor in the coronal section.
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Figure 10 Accumulative and differential dose-volume
histograms at tumor area in coronal section.
corresponds to the film segment between isodose curves
of 60 to 80%.
Isodose curves generated during planning were smooth,
covering the tumor with 100% of the prescribed dose
(Figure 2C). Values measured show a non-uniform dose
on film samples, varying from 105 to 115% PD, and
some hotspots with 115 to 120%. Such non-uniform dose
distribution, compared to planned isodose curves, is due
to the heterogeneous features of the physical phantom,
including bone, brain and the GBM simulator itself. Such
structures, made of distinct tissues with different densities
and chemical compositions, create variations in radiation
absorption as compared to that of water.
Figure 8 presents the dose percentage deviations from
red to green components. In the Sagittal Posterior (SP)
film, there are deviations from -4 to -2% in a small area.
Large areas in SP and Sagittal Anterior (SA) films present
discrepancies of 0 to 2%. SA film presents areas from 4
to 6% deviation. In the Coronal (C) film, there are large
areas of -4 to -2% and of +2 to +4% deviations. It is unclear
whether the spatial representation of such discrepancies is
meaningful. Film response at green and red are in distinct
wavelengths and intensities. The red response provided
higher response than green. In this experiment, the OD
response interval for green was up to 0.217 while in red,
it was 0.280. This means that the red component is more
sensitive than the green one.
Application of the gamma index criteria to a target area
of interest represented by the tumor was indicated. It was
not applied to all of the bidimensional plane of measured
data set compared to the TPS, since many discrepancies
correspond to highlights due to high dose gradient regions
at the interface of the irradiation window, as well as impre-
cise superposition between measured data and isodose
TPS distributions, due to the lack of internal reference
points. However, tumor identification was easily obtained
from CT image, equivalent-tissue differences and physical
tumor parameter differences, such as color and texture on
the phantom. Themain benefit from applying the gamma-
index method to the tumor is comparing actual measured
doses to calculated ones.
As demonstrated by the cumulative DVH, the tumor
received a homogeneous dose. Since the cumulative DVH
appeared as a horizontal line at the top of the graph,
100% of the volume received 82% of the maximum dose,
206.6 cGy, and no volume received higher than 90% of the
measured dose. Dose spots present on the film alter the
measured DVH from 90% up to 100%.
The value of 100% was normalized to the 97% of the
overall prescribed dose of 200 cGy, which means that
100% corresponds to 206.2 cGy. The TPS provided a vol-
ume in which the tumor is enclosed with a dose at list
superior to the 206.2 cGy. The DVH histogram for the
whole tumor volume fromTPS provided amaximum dose
of 104% and an average dose of 102.3%, whichmeans 210.9
cGy. Therefore, the tumor volume is covered by 214.4 cGy
evaluated by the TPS. The precision error of the CAT3D
TPS program provided a variation error to different pro-
tocols. The closest protocol tested to our experiment was
a four two-opposite size irradiation field, providing a error
of -3%. Therefore, it seems that the TPS may sub-estimate
the dose up to -3%, which means the tumor dose shall be
close to 220.8 cGy [35].
Few physical dark spots on the irradiation film respon-
sible to high dose at the pixel level at the resolution of 0.1
mm per pixel. Since they are physical optical response of
the crystals on the film, they were enclosed to the dose
response measurements in the same resolution level. One
can question if those spots provide precise dose responses
in such resolution. Indeed, the film is intended for dose
measurement at spatial resolution up to 0.1 mm, which it
is the limit that our experiment is performed. At a higher
spatial resolution the light transmission becomes increas-
ingly noisy and the dose measurement of tiny pixel is
less accurate. However, low dose spots were not observed.
Also, Devic et al. [31] suggested that the averaging of the
film response and a Wiener filter application are require-
ments to remove the“bad” pixels. However, on this article,
the data were shown at it is. There is the possibility that
those pixels are not representative of the dose profile.
Further investigation shall confirm the high dose spots
at the high resolution level and may be removed of the
measurement set of data.
The uncertainty determinations follow ISO guide as
suggested by [30]. There aremany uncertainties that affect
the applied method. Table 1 presents a summary of the
variables that may influence the reproducibility of the
dose measurements at the high energy photon beam con-
dition, the head and neck phantom and the radiochromic
film EBT. At present, the uncertainties associated to many
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Table 1 Some variables that may affect measurement reproducibility
Categories Variables
Dose calibration in solid water phantom PDD calibration (0.8% uncertainty [30])
and beam calibration Ionizing chamber dosimeter calibration (0.6% uncertainty [30])
Beam radiation calibration (1.4% uncertainty [30])
Radiochromic film conditions Differences in lots or sheets of film
Film manipulation
Environmental conditions (manipulation and storage)
Calibration film irradiation Size and number of samples
Film placement in the water phantom
Beam orientation and isocenter positioning
Scanning procedure Post-irradiation waiting period
Film batch
Environmental conditions during scan
Multiple scan passes count
Scanner type and equipment conditions
Resolution of the scanned image
Physical phantom Homogeneity and heterogeneity of the equivalent tissues and tumor
Positioning and repositioning of the phantom on the irradiation table
and support
Positioning of the affixed external reference points
Film affixing inside the synthetic brain and tumor
Phantom Tomography Phantom positioning and repositioning
Reference points
Image capture and resolution
Calibration and curve fitting Film set count / dataset size
Choice of calibration method / equation
Adjustment method
Experimental irradiation measurements Irradiation procedure
Reproducibility of LINAC conditions
TPS planning Mathematical method
Dose image representation
Inhomogeneity in CT application
Image processing Discrepancies in image scaling
Resolution, contrast, uniformity of a region of interest (ROI)
Noise
Imaging and treatment of coordinate coincidences
of those variables are unclear. Further investigation will be
performed to evaluate the combined total uncertainty for
the experiment.
The determination of absorbed dose in water with the
15 MV beam, the uncertainties in the different phys-
ical quantities, and procedures that contribute to the
dose determination shall consider uncertainties up to the
calibration of the reference dosimeter at the standards
laboratory and the uncertainties associated with the
measurements at the reference point in a water phantom.
The uncertainties in the various steps are combined in
quadrature, yielding the combined standard uncertainty
for the determination of the absorbed dose to water at
the reference point. The uncertainties in the calibration
of the 15 MV beam were estimated as 1.5%. Regarding
the uncertainties on the PDD, those are included on the
beam calibration, which is estimated as 0.8%. Therefore,
an estimated value of 2.3% uncertainty was assumed.
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It was possible to verify absorbed doses deposited on
the synthetic tumor target, validating the conformal 3D,
three-field, T-shaped, radiotherapy protocol. The phys-
ical phantom, including the GBM simulator positioned
at the center of the brain, was essential to performing
the dosimetry. Dosimetric findings showed how relevant
was the physical anthropomorphic and anthropometric
phantom to our studies, as compared to water phantoms.
The latter are made of homogeneous material and do
not reproduce mass attenuation deviation from water due
to different structures, such as skull and brain, as well
as deviation on tissue densities of the physical head and
neck phantom. Those variations may introduce uncer-
tainty on dose, particularly on interfaces where electronic
equilibrium is disturbed.
The physical head and neck phantom may be disassem-
bled and its brain manipulated in order to insert dosime-
ters. Positioning of the film-based dosimeters inside the
brain structure and the synthetic tumor were adequate,
i. e. with no damage to the skull or to the rest of the
phantom structures. Radio opaque reference points were
essential to lining up during planning, irradiation and dose
analysis. Synthetic anatomic structures as the brain and
the skull were identified on the CT images, demonstrating
their radiological equivalency. The tumor simulator pre-
sented an heterogeneous physical aspect equivalent to a
real GBM.
The physical phantom with synthetic tumor, the radio-
therapy planning and the irradiation protocol in a T-
shaped pattern at Luxemburgo Hospital in GBM cases, all
contribute to make this simulation very realistic, allowing
measurements with dosimeters based on EBT2 film.
Future studies shall include several diffuse tumor
volumes placed into the brain, with varying sizes and
locations, simulation of elements such as edema and hem-
orrhages, distinct tumor densities and inhomogeneous
characteristics, or distinct radiation protocols and beam
spectra.
Conclusion
We investigated EBT2 film irradiation with head and
neck 3D-Conformal Radiotherapy treatment plan using
an anthropomorphic and anthropometric head and neck
phantom using the gamma analysis criterion of 3mm3%
and histogram comparisons. Dosimetric experiments per-
formed on a physical phantom, reproducing the irradia-
tion protocol of 15MV 3D-Conformal Radiation Therapy,
T-shaped, allowed spatial dose distribution determination
on the GBM simulator. Measured absorbed dose on the
simulator achieved 70 to 120% of the prescribed values
from radiotherapy planning, and showed stratified hot
regions. It was demonstrated that Gafchromic EBT2 film,
either on red or on green components, may be used as
cross-reference for a dose range from 20 to 240 cGy, since
both components present comparable dose responses
with maximum deviation from 2 to 6% respectively, how-
ever, they are dependent variable. Dose deviation percent-
age results indicate almost all points within 1-3% and 3-5%
deviation intervals, and a few in the 9-11% interval. Few
dark spots in the film caused the appearance of outlier
points in the 13-15% interval of dose deviation. On the
other hand, DVH results show that the tumor received a
homogeneous dose: 100% of the volume received 82% of
the maximum dose. No volume received higher dose than
90% of the measured dose. The remainder of the mea-
sured DVH, 90% to 100%, is due to those isolated, higher
dose dark spots. 83.2% of the points with a gamma value
of less than 1 (3%/3mm) for TPS and experimental values,
respectively. At the tumor, measured at coronal section, a
few dark spots in the film caused the appearance of out-
lier points in 13-15% of dose deviation percentage. And, as
final conclusion, such dosimeter choice and the physical
anthropomorphic and anthropometric phantom provided
an efficient method for validating radiotherapy protocols.
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